{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:58:15Z","timestamp":1759564695061},"reference-count":27,"publisher":"Wiley","issue":"S152","license":[{"start":{"date-parts":[[2011,1,7]],"date-time":"2011-01-07T00:00:00Z","timestamp":1294358400000},"content-version":"vor","delay-in-days":7676,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[1990,1]]},"abstract":"<jats:p>No single pharmacologic agent has been more widely studied than the oral contraceptive (OC). Scientific efforts have been directed primarily toward maximizing the benefits of OCs\u2014which remain the most effective, reversible form of birth control\u2014while minimizing their potential risks, specifically thromboembolic disorders and cardiovascular disease.<\/jats:p><jats:p>Decreases in the dose of estrogen from the 100 \u03bcg\u2014150 \u03bcg levels of the 1960s to the 30 \u03bcg\u201450 \u03bcg formulations of today have been accompanied by dramatic reductions in the risk of thromboembolic events. In healthy women not predisposed to these conditions, the risk of thromboembolism is now considered very small. Similar reductions in the doses of progestin have also resulted in decreases in the incidence of stroke and myocardial infarction.<\/jats:p><jats:p>Evidence suggests that not only dose but androgenic activity of a progestin may negatively impact on risk of cardiovascular disease. Thus development of OCs containing a progestin with the least potential for androgenically mediated side effects appears to be advisable.<\/jats:p>","DOI":"10.3109\/00016349009156500","type":"journal-article","created":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T17:53:11Z","timestamp":1260294791000},"page":"7-12","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The Evolution of Oral Contraceptives: Maximizing Efficacy, Minimizing Risks"],"prefix":"10.1111","volume":"69","author":[{"given":"Bernard","family":"Hedon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,7]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00325481.1987.11699698","article-title":"Oral contraceptives. The benefits and the cardiovascular risks","volume":"81","author":"Connell E B.","year":"1987","journal-title":"Postgraduate Medicine"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.2307\/2134636"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91435-1"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(79)90111-2"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320480026020"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320290021022"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198003063021004"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03330360036032"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198703123161102"},{"key":"e_1_2_1_11_1","first-page":"1602","article-title":"Oral contraceptive use and the risk of endometrial cancer","volume":"249","author":"Centers for Disease Control and Women's Health Study","year":"1983","journal-title":"JAMA"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jama.1987.03390060086029","article-title":"Combination oral contraceptive use and the risk of endometrial cancer","volume":"257","author":"Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development","year":"1987","journal-title":"JAMA"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112313052701"},{"key":"e_1_2_1_14_1","volume-title":"Making choices: evaluating the health risks and benefits of birth control methods","author":"Ory H W.","year":"1983"},{"issue":"7","key":"e_1_2_1_15_1","first-page":"513","article-title":"Oral contraceptives: the current risk\u2010benefit ratio","volume":"29","author":"Connell E B.","year":"1984","journal-title":"J Reprod Med"},{"key":"e_1_2_1_16_1","first-page":"727","article-title":"Royal College of General Practitioners' Oral Contraception Study","volume":"2","author":"Mortality among oral\u2010contraceptive users","year":"1977","journal-title":"Lancet"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)90236-7"},{"key":"e_1_2_1_18_1","volume-title":"The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives","author":"Ramcharan S.","year":"1974"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5703.203"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6224.1157"},{"key":"e_1_2_1_21_1","first-page":"1","article-title":"Oral contraceptives and nonfatal vascular disease","volume":"66","author":"Porter J B.","year":"1985","journal-title":"Obstet Gynecol"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91745-2"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0002-9378(16)32485-1","article-title":"Progestogens and arterial disease\u2010Evidence from the Royal College of General Practitioners' Study","volume":"142","author":"Kay C R.","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(66)92979-5"},{"key":"e_1_2_1_25_1","first-page":"25","article-title":"Recent biological studies in relation to low dose hormonal contraceptives","volume":"5","author":"Briggs M H.","year":"1979","journal-title":"Br J Fam Plann"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-53-6-1123"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)32486-3"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197807062990104"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.3109%2F00016349009156500","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.3109\/00016349009156500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T18:35:05Z","timestamp":1697999705000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.3109\/00016349009156500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":27,"journal-issue":{"issue":"S152","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["10.3109\/00016349009156500"],"URL":"https:\/\/doi.org\/10.3109\/00016349009156500","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]},"assertion":[{"value":"2011-01-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}